When capability is real — but deciding alone feels risky.
The product is moving.
Your company may already be building around it.
AI may be shaping research, recommendations, customer expectations, internal decisions,
or the story your company is beginning to defend.
That is exactly when this diagnostic matters.
The Interpretation Gap™ Diagnostic is a fixed-scope review for founders and CEOs of AI-native companies who need to know whether the next move is safe to accelerate.
$7,500 fixed-scope diagnostic
Delivered in days, not weeks
You will not notice the freeze. You will call it progress.
This is not an audit.
It is not a roadmap.
It is not a general advisory engagement.
It exists to answer one high-stakes question before the next move gets expensive:
Are you dealing with an execution problem,
or are you building speed on top of a decision your company has not classified correctly yet?
Everything follows from that distinction.
Whether to accelerate.
What to pause.
What needs another look before more people, money, systems or commitments depend on it.
And what becomes dangerous to keep describing loosely.
The Interpretation Gap™ Diagnostic looks at the places where judgment may already be moving
before anyone has formally called it authority.
That can include:
The issue is not whether AI makes the final decision.
The issue is whether the company can still see how the interpretation behind that decision was formed.
A short, focused judgment intervention that gives you:
The outcome is not more activity.
It is knowing what not to accelerate yet.
This diagnostic is for founders and CEOs of AI-native companies where capability is real,
but internal confidence is not stable enough to carry the next irreversible move safely.
Most often, that looks like this:
This is especially relevant for companies in:
This is a short, fixed-scope review designed to find where confidence is breaking
before the company builds further around it.
It examines where explanation, trust and decision ownership
are starting to separate across the business.
That may show up in:
The diagnostic does not begin by asking whether the company has an AI problem..
It asks what the company has already started depending on.
This diagnostic is not designed to:
Those may become relevant later.
But only after the company knows what it is actually dealing with.
Direction given too early becomes noise.
This is worth doing when the next move in the company could be expensive to reverse within 90 days.
For example:
If the next move is easily reversible, this diagnostic is unnecessary.
If it hardens hiring, customer expectations, cost structure, trust, or valuation assumptions, it usually is not.
The cost here is rarely immediate failure.
It is usually a quieter form of exposure:
Most teams do not fail because nothing works.
They stall because something starts working before it can still be interpreted safely.
This kind of inspection has surfaced issues including:
The pattern is usually the same.
The company looks like it has an execution problem.
But the expensive issue started earlier.
This diagnostic is the entry point.
Not the entire engagement.
If the conclusion is that the real constraint is execution, downstream work may follow.
But only after the problem is classified correctly.
That sequence matters.
Teams often spend far more trying to stabilize confidence after the wrong decision has already hardened.
This work exists to intervene earlier, while the cost is still lower.
$7,500 fixed-scope diagnostic
Delivered in days, not weeks.
Priced against the cost of misclassification, not the cost of analysis.
Most teams recover this investment by avoiding one wrong acceleration decision.
There is no obligation to proceed beyond the diagnostic.
If a decision in your company would become expensive to reverse within 90 days, this is designed for that moment.